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Abstract 21 
Prenatal levels of organohalogen compounds (OHCs), including polybromodiphenyl 22 
ethers (PBDEs), polychlorobiphenyls (PCBs), hexachlorobenzene (HCB), 23 
hexachlorocyclohexanes and DDTs have been investigated in two different cohorts 24 
from the Spanish Mediterranean area, Valencia and Menorca, by analysis of cord 25 
blood serum. Comparison of the observed median concentrations to other cohorts 26 
show low PBDE levels (2.8-6.8 ng/g lipid) but high values of HCB (0.68 ng/ml, 260 27 
ng/g lipid) and PCBs (0.65 ng/ml, 240 ng/g lipid) in the cohort of Menorca indicating 28 
that Mediterranean areas, and not only high latitude regions, may contain population 29 
groups highly exposed to some of these pollutants. Significant differences in the 30 
concentrations of these compounds have been found between the two cohorts. 31 
Differences in maternal population such as age or body mass index cannot explain this 32 
variation. One possible cause of variability is the seven year time period elapsed 33 
between the two cohort recruitments but the strong differences observed do not allow 34 
exclusion of local diet differences. Thus, the different average PCB congener 35 
distributions between the two cohorts suggests an influence from materials containing 36 
diverse PCB mixtures. The congener mixtures found in Menorca could reflect a diet 37 
contribution from some western Mediterranean fish species. These results provide 38 
baseline information on prenatal OHC background levels in the Mediterranean area. 39 
 40 
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1. Introduction 41 
 42 
Organohalogen Compounds (OHCs) such as DDTs, hexachlorocyclohexanes (HCHs), 43 
hexachlorobenzene (HCB), polychlorobiphenyls (PCBs) and polybromodiphenyl 44 
ethers (PBDEs) are widespread toxic environmental pollutants which have been 45 
extensively used as pesticides, flame retardants, hydraulic fluids and in many other 46 
industrial applications1. OHCs have been released into the environment as a 47 
consequence of human activity for many years. They are persistent, ubiquitous and 48 
highly lipophilic so they bioacumulate and biomagnify through the food chain2.  49 
In Spain and in many other western countries, use of organochlorine 50 
compounds (OCs) started in the 1930s and lasted until the end of the 1970s when they 51 
were highly restricted. In contrast, PBDE production was initiated in 1970s. 52 
Manufacture of the technical penta- and octa-BDE mixtures ceased around 20043 but 53 
production of decaBDE is still going. Some commercial mixtures of these compounds 54 
are still in use4. In 2004, the Stockholm Convention (SC) on Persistent Organic 55 
Pollutants (POPs) banned twelve of these compounds5, including PCBs, DDT and 56 
HCB. However, use of DDT for malaria control is still in use in tropical areas. In the 57 
last few years, some new pollutants have been added to the above mentioned list, such 58 
as certain components of the pentaBDE and octaBDE mixtures and α-, β- and γ-HCH 59 
isomers6. As a consequence of these regulatory restrictions, OC levels have 60 
diminished in biota and human tissues in many countries7. Concerning PBDEs, the 61 
observed trends do not show a common feature8,9.  62 
OHC monitoring in humans during the early age stages is important. During 63 
pregnancy these compounds are transferred from mother to fetus through the 64 
placenta10. Fetuses are more vulnerable than adults as their immune systems and 65 
detoxification mechanisms are not fully developed. OHCs may therefore cause 66 
damage and may predispose to prospective health problems11. Previous studies have 67 
shown that exposure to certain OHCs may influence fetal and early childhood 68 
growth12 or fetal loss13. It has also been shown that some of these compounds have 69 
deleterious effects on attention in the school period14 and on social behaviour at 4 70 
years of age15. 71 
In Mediterranean countries there is very limited information on prenatal 72 
exposure to OHCs16-19. Furthermore, the available information needs to be discussed 73 
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in terms of geographic variability and possible temporal differences related to the 74 
periods of use of these compounds, namely OCs vs PBDEs.  75 
In order to contribute to fill this gap, concentrations of OHCs in cord blood 76 
serum from two Mediterranean Spanish cohorts, Valencia and Menorca (Fig. 1), are 77 
described in the present study. Cord blood serum taken upon child birth is a good 78 
medium for description of the in utero exposure to the OCH. They provide 79 
information of the exposure levels in this first life stage. 80 
The island of Menorca is a popular tourist destination with strong agricultural 81 
activities. Cattle rising for milk production is important, which has involved an 82 
extensive use of the land for pasture20. The island does not contain any large factory. 83 
A portion of the inhabitants are fishermen and people have easy access to fish and 84 
seafood. The hospital where mothers and children were recruited belongs to the public 85 
health service of the Balearic Islands and collects a large proportion of the births in 86 
the whole island. 87 
Valencia is a coastal city located in the eastern shore of the Iberian Peninsula. 88 
The cohort was recruited in Hospital La Fe which belongs to the public health system 89 
of the Valencian Community. This hospital gives service to an area of 1372 km2 (Fig. 90 
1) including 34 municipalities with a reference population of approximately 300,000 91 
inhabitants. This population has wide socio-demographic and environmental 92 
heterogeneity that can be divided into an urban zone (city of Valencia), a densely 93 
populated metropolitan zone, a semi-urban zone encompassing industrial and 94 
agricultural activities as well as residential areas, and a wide rural zone in which 95 
extensive aquiculture is developed. No large factories are located in the area. Fish is 96 
also a common constituent in the diet of people belonging to these four groups. 97 
The distance between the two cohort locations is about 400 km. Both 98 
communities are situated in typical Mediterranean sites and can be assumed to have 99 
similar exposure scenarios. The mothers living in these areas are likely exposed to 100 
baseline OHC levels of western Mediterranean locations. 101 
The present study is devoted to describe the OHC concentrations in cord blood 102 
serum of these communities and to identify their similarities and differences providing 103 
a reference standard for other populations from Mediterranean areas and from other 104 
biogeographical groups. 105 
 106 
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2. Material and Methods 107 
 108 
2.1 Populations and recruitment 109 
 110 
The participant newborns in our population of study (n = 265) were recruited in the 111 
context of the cross-sectional INMA project (Spanish Children´s Health and 112 
Environment) which is a prospective multi-center pregnancy and birth cohort study on 113 
general population21. The present work includes the analysis of two INMA cohorts, 114 
Valencia and Menorca (Fig. 1). The Menorca cohort recruited all women presenting 115 
for antenatal care over 12 months from mid 1997 to 1998. 482 children were enrolled. 116 
The study design details are reported elsewhere22. Here data for a subset of 91 117 
newborns is presented. In the Valencia cohort, deliveries took place between May 118 
2004 and February 2006. During this period 787 women gave birth to a live infant. 119 
500 of them allowed collection of cord blood for OHCs analysis23. Here we report 120 
OHC levels for a subset of 174 newborns. All mothers who agreed to participate in 121 
either study signed a written informed consent before inclusion. Both Valencia and 122 
Menorca protocols were approved by their respective ethics committees, the former in 123 
Hospital La Fe and the latter in the Municipal Institute of Medical Research from 124 
Barcelona. 125 
 126 
2.2  Materials 127 
 128 
Materials, laboratory analytical methods and quality control procedures have been 129 
described elsewhere24. Standards of tetrabromobenzene (TBB), PCB 209, PCB 142 130 
and PCB 200 were purchased from Dr Ehrenstorfer GmbH (Wesel, Germany). α-131 
HCH, β-HCH, γ-HCH, δ-HCH, HCB, pentachlorobenze (PeCB), 4,4'-DDT, 2,4’-DDT 132 
and their metabolites, 4,4’-DDE, 2,4’-DDE, 4,4’-DDD, 2,4’-DDD, and PCBs 133 
(congeners 28, 52, 101, 118, 153, 138 and 180) were also purchased from Dr 134 
Ehrenstorfer. The PBDE standards were contained in two analytical solutions, EO-135 
5099 (BDE 1, 2, 3, 7, 8, 10, 11, 12, 13, 15, 17, 25, 28, 30, 32, 33, 35, 37, 47, 49, 66, 136 
71, 75, 77, 85, 99, 100, 116, 118, 119, 126, 138, 153, 154, 155, 166, 181, 183 and 137 
190) and EO-5103 (BDE 17, 28, 47, 66, 71, 85, 99, 100, 153, 154, 138, 183, 190 and 138 
209), that were purchased from Cambridge Isotope Laboratories, Inc (Andover, MA, 139 
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USA). 13C-BDE 209 and BDE 118 were purchased in a certified standard (50 μL/mL). 140 
All standard solutions were of 98% purity at least. They were prepared in isooctane 141 
for trace organic analysis. This isooctane and analytical grade concentrated sulfuric 142 
acid and n-hexane were purchased from Merck (Darmstadt, Germany). 143 
 144 
2.3 Serum extraction and clean up 145 
 146 
Briefly, 1 ml of cord serum was spiked with the surrogate standards TBB and PCB 147 
209 (vortex stirring for 30 s at 2,000 rpm). n-Hexane (3 ml) was added followed by 2 148 
ml of concentrated sulfuric acid. After reaction, the mixture was stirred for 30 s and 149 
the supernatant n-hexane phase was separated by centrifugation. The remaining 150 
sulfuric acid solution was re-extracted two times with 2 ml of n-hexane (stirring 30 s). 151 
The combined n-hexane extracts (7 ml) were additionally cleaned with 2 ml of 152 
sulfuric acid (stirring 30 s). Then, the n-hexane phase was separated and reduced to 153 
dryness under a gentle nitrogen stream. The extract was transferred to gas 154 
chromatography (GC) vials using four rinses of 25 μl of isooctane. PCB 142 was 155 
added as injection standard for OHCs analysis. 156 
 157 
2.4 Lipid determination 158 
 159 
In the samples from the Menorca cohort, total serum lipids were determined by 160 
gravimetry17. In the Valencia cohort sample lipid concentrations were calculated from 161 
total cholesterol and triglycerides25. These compounds were measured in the General 162 
Biochemistry Laboratory of Hospital La Fe using enzymatic methods. 163 
 164 
2.5 Analysis of organochlorine compounds 165 
 166 
OC concentrations were determined by GC with electron capture detection (GC-ECD) 167 
using an Agilent 6890N GC with a Micro-ECD (Agilent Technologies, Palo Alto, 168 
CA, USA) equipped with a DB-5 fused silica capillary column of 60 m length, 0.25 169 
mm internal diameter and 0.25 µm film thickness (J & W Scientific, Folsom, Ca, 170 
USA). Details on operating conditions, identification, quantification and quality 171 
control procedures have already been described24. 172 
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 173 
2.6 Analysis of polybromodiphenyl ethers 174 
 175 
After OC analysis by GC-ECD, vials samples were re-evaporated under a nitrogen 176 
stream and 20 μl of BDE 118 and 10μl of [13C]-BDE 209 were added as internal 177 
standards. PBDEs from the Valencian cohort were determined using an Agilent 178 
6890N GC coupled to a 5975 mass spectrometer (GC-MS) (Agilent Technologies) 179 
operating in electron capture negative ionization (ECNI) mode. The instrument was 180 
equipped with a low bleed SGE-BPX5 MS fused silica capillary column (15 m length, 181 
0.25 mm internal diameter and 0.10 μm film thickness). PBDEs from the Menorca 182 
cohort were determined with a HP 5973 MSD GC-MS (Agilent Technologies) 183 
operating in NICI mode. Samples were injected in splitless mode onto a DB-5 fused 184 
silica capillary column of 60 m length, 0.25 mm internal diameter and 0.25 µm film 185 
thickness (J & W Scientific). Details on operating conditions, identification and 186 
quantification processes have been described elsewhere24,26. 187 
 188 
2.7 Reference materials 189 
 190 
Reference materials obtained from the Arctic Monitoring and Assessment Program 191 
(AMAP) were used to assess precision and accuracy of the analytical methods used. 192 
The laboratory is in compliance with the AMAP Ring Test Proficiency Program for 193 
persistent organic pollutants in human serum including lipid analysis (Institut 194 
National de Santé Publique du Québec, Canada). 195 
 196 
2.8 Data analysis 197 
 198 
Standard descriptive statistics were calculated for OHC concentrations. OHCs values 199 
were lipid-adjusted dividing serum residue levels by total serum lipid. A value of zero 200 
was used for data analysis when measurable quantities of the analytes were below 201 
limit of detection. For comparison, descriptive analysis was limited to contaminants 202 
which were measured in the two cohorts. The Mann-Whitney U test was used to 203 
examine OHC differences between the two cohorts. Statistical significance was 204 
considered at p<0.05 (two sided). Statistical analysis was performed with the 205 
Statistical Package for Social Sciences version 15.0 (SPSS Inc., Chicago, IL, USA). 206 
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3. Results  208 
 209 
3.1. Population of study 210 
 211 
The characteristics of the maternal and newborn participants in the cohorts of 212 
Valencia and Menorca are described in Table 1. When using standardized categories 213 
for body mass index (BMI), a significant higher proportion of overweight (>26 kg/m2) 214 
and obese mothers (>30 kg/m2) were found in the Valencian cohort (29.9% and 215 
10.9% respectively) than in Menorca (12.1% and 3.3%, respectively). Thus, the 216 
average BMI was statistically significantly higher in Valencia than in Menorca (Table 217 
1). Mothers from Menorca (average age 28.5 yr) were slightly younger than those 218 
from Valencia (average age 30.1 yr) and the difference was statistically significant 219 
(Table 1). The main difference concerned the proportion of mothers older than 35 yr 220 
which was higher in Valencia (18.4%) than in Menorca (4.4%). No statistically 221 
significant differences were observed in other maternal features such as previous 222 
lactation and education level. 223 
The newborn characteristics of both cohorts were comparable concerning 224 
gender, gestational age and birth weight. However, the Valencian newborns were 225 
significantly taller than those from Menorca (Table 1). 226 
 227 
3.2 Concentrations of polybromodiphenyl ethers 228 
 229 
Means, standard deviations, medians, percentiles and concentration ranges of the 230 
PBDE congeners analyzed and found in concentrations above quantification limits in 231 
the Valencia and Menorca cohorts are shown in Table 2. The distributions are 232 
dominated by BDE 47 contributing to 38% and 51% of total PBDE in Valencia and 233 
Menorca, respectively (Fig. 2). BDE 99 and BDE 100 are the second most abundant 234 
congeners (Table 2). In contrast, BDE 153 is not found in any of the Menorca cohort 235 
samples while it is observed in 52% of the samples from the cohort of Valencia (Fig. 236 
2). BDE 183 is found in both cohorts but in much higher proportion in Valencia 237 
(~5%) than in Menorca (~1%). In both cases, the observed distributions essentially 238 
correspond to the commercial pentaPBDE mixtures. The higher proportion of BDE 239 
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183 in the cohort of Valencia suggest some small contributions of octaPBDE in this 240 
area. 241 
The mean values of total PBDEs are 11 and 5.4 ng/g lipids in Valencia and 242 
Menorca, respectively (Table 2). The median values provide more representative 243 
figures for comparison with previously reported data from other cohorts. These 244 
values, 2.8 and 6.8 ng/g lipid in Menorca and Valencia cohorts, respectively, are low 245 
in comparison to other studies (Table 3). Thus, median concentrations in the range of 246 
18.4-39 ng/g lipid have been reported in cord blood serum from several cohorts from 247 
the USA32-35. Median concentrations above 10 ng/g lipid have also been reported in 248 
Madrid (Spain)18, Toulouse (France)27 and Guiyu (China)38 (Table 3). Intermediate 249 
median concentrations between the Valencian and Menorcan values, 3.3-3.9 ng/g 250 
lipid, have been reported in Singapore36, South China28 and Groningen (The 251 
Netherlands)30. Median PBDE concentrations below those observed in the cohort of 252 
Menorca have only been reported in Sweden, Copenhagen (Denmark) and Japan, 253 
1.69, 0.95 and 0.65 ng/g lipid, respectively29,31,37 (Table 3). 254 
 255 
3.2 Concentrations of polychlorobiphenyls 256 
 257 
Means, standard deviations, medians, percentiles and concentration ranges of the PCB 258 
congeners analyzed in the cohorts of Valencia and Menorca are shown in Table 4. The 259 
distributions are dominated by CB 180 in Menorca and CB 153 and CB138 in 260 
Valencia (Fig. 3). The higher chlorinated congeners, CB 118, CB 153, CB 138 and 261 
CB 180, are those most abundant in both cohorts (Fig. 3). The median concentrations 262 
of total PCBs (the seven congener analyzed) in Valencia, 0.38 ng/ml (150 ng/g lipid), 263 
are nearly half those in Menorca, 0.65 ng/ml (240 ng/g lipid). The concentrations 264 
from the cohort of Menorca are higher than those reported in many other sites (Table 265 
5)10,31,32,39,41-57 except Michalovce (Slovakia)45 and Chukotka (Russia)48. The cohort 266 
from Valencia exhibits concentrations more in the average. Besides the above 267 
mentioned populations, they are lower than those described in North Netherlands44, 268 
Faroe Islands47, Quebec50 and Northern Quebec49, and Zhejiang (China)55. 269 
 270 
3.3. Concentrations of hexachlorobenzene 271 
 272 
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Statistical data of the concentrations of HCB in both cohorts are shown in Table 6. 273 
The median values of Valencia, 0.24 ng/ml (47 ng/g lipid), are less than half those in 274 
Menorca, 0.68 ng/ml (260 ng/g lipid). Pentachlorobenzene was found above limit of 275 
detection in less than 10% of the samples from both cohorts. These data are therefore 276 
not reported. The observed HCB concentrations in the cohort of Menorca are high in 277 
comparison with those found in previous studies (Table 5). Only the cord blood 278 
concentrations from Ribera d’Ebre (Catalonia, Spain)10 exhibit higher values than 279 
Menorca. However, Ribera d’Ebre cohort belongs to a geographical area that contains 280 
the village of Flix whose inhabitants exhibit the highest HCB concentrations ever 281 
described in general population58-60 as a consequence of the emissions from a chloro-282 
alkali factory. The high concentrations found in newborns of Ribera d’Ebre10 is 283 
consistent with these previous observations. Considering previous studies (Table 5), 284 
the concentrations in the cohort of Valencia are also high. Besides Ribera d’Ebre10, 285 
the only literature references describing higher cord blood concentrations than in 286 
Valencia refer to Chukotka (Russia)48 or Veracruz (Mexico)52. The high values from 287 
the Valencian and Menorcan cohorts are consistent with the HCB levels of Spanish 288 
general population (not newborns) described in previous studies that are higher than 289 
in other European countries61. 290 
 291 
3.4. Concentrations of hexachlorocychlohexanes 292 
 293 
Statistical data on the concentrations of β-HCH in the cohorts of Valencia and 294 
Menorca are shown in Table 6. γ-HCH, δ-HCH and α-HCH were found above 295 
detection limit in less than 10% of the samples and therefore are not included in the 296 
Table. The median concentrations in the cohort from Menorca, 0.19 ng/ml (60 ng/g 297 
lipid), are again higher than those from Valencia, 0.092 ng/ml (35 ng/g lipid). These 298 
concentrations are lower than those found in cohorts from sites such as Ribera d’Ebre 299 
(Catalonia, Spain)10, Chukotka (Russia)48, Veracruz (Mexico)52, Rio de Janeiro 300 
(Brazil)53, New Delhi (India)56 or Singapore57 and higher than those found in 301 
Wielkopolska (Poland)46, Artic Canada51, Chiba and Yamanashi (Japan)54 or Zhejiang 302 
(China)55. 303 
 304 
3.5. Concentrations of DDTs 305 
 306 
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The concentrations of 4,4’-DDE and 4,4’-DDT are also reported in Table 6. The 307 
median values in Valencia were 0.53 ng/ml (210 ng/g lipid) and below limit of 308 
detection for 4,4’-DDE and 4,4’-DDT, respectively. In Menorca they were 0.94 ng/ml 309 
(360 ng/g lipid) and 0.03 ng/ml (11 ng/g lipid) for 4,4’-DDE and 4,4’-DDT, 310 
respectively. The higher concentrations of 4,4’-DDE than 4,4’-DDT are consistent 311 
with an old origin of this mixture of pollutants since the latter is the one used as 312 
pesticide and the former is a transformation compound. The observed concentrations 313 
of 4,4’-DDE in these two cohorts are lower than those found in countries that have 314 
recently used DDT for Malarian control such as Oaxaca (Mexico)41, Veracruz 315 
(Mexico)52 and New Delhi (India)56 but higher than those found in other sites such as 316 
Brescia (Italy)39, Flanders (Belgium)42, Faroe Islands (Denmark)47, Quebec 317 
(Canada)50, Arctic Canada51, Maryland (USA)32, Rio de Janeiro (Brazil)53, Chiba and 318 
Yamanashi (Japan)54 or Zhejiang (China)55. Intermediate values between those in 319 
Valencia and Menorca have been reported in Ribera d’Ebre (Catalonia, Spain)10, 320 
Wielkopolska (Poland)46, Chukotka (Russia)48, Northern Quebec (Canada)49 and 321 
Singapore57. 322 
 323 
4. Discussion 324 
 325 
In Spain OC pesticides were widely used from 1950 until mid seventies, although 326 
specific informations on the zones considered in this study are very scarce. The two 327 
areas are characterized for having a strong agricultural activity and most likely OC 328 
pesticides were intensively used. The observed DDT/DDE ratios are very low, 0.08 in 329 
both cohorts, indicating old exposure.  330 
The distributions of HCB, β-HCH, total DDTs, total PCBs and total PBDEs 331 
(Figure 4) are statistically different between the two cohorts according to the Mann-332 
Whitney U test. As mentioned in the results section, the median concentration 333 
differences between the cohorts of Valencia and Menorca are significant. Comparison 334 
of the maternal characteristics between the two cohorts showed significant differences 335 
for age and BMI but not for the records of previous lactation or educational level. 336 
Mothers from Menorca were statistically significantly younger than those from 337 
Valencia, 28.5 and 30.1 yr, respectively. Statistically significant associations between 338 
higher concentrations of OCs in cord blood and older maternal age have been found 339 
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for HCB50,62,63, 4,4’-DDE10,50,62, 4,4’-DDT62, β-HCH62 and PCBs32,50,62,63. This trend 340 
is the opposite between maternal age and cord blood concentration differences of the 341 
cohorts of Valencia and Menorca. Average maternal ages of the two cohorts cannot 342 
therefore justify the observed cord blood differences.  343 
On the other hand, while several previous studies did not find any association 344 
between maternal age and cord blood PBDE concentrations, a negative trend was 345 
found with statistical significance in one of them, involving lower PBDE 346 
concentrations in cord blood at higher maternal age32. According to these results, 347 
maternal age differences here are not explaining differences on PBDE levels in the 348 
cohorts of Valencia and Menorca since mothers from Menorca are younger. 349 
The mothers from the cohorts of Menorca exhibit statistically significantly 350 
lower BMI than those from the cohort of Valencia, 22.5 and 24.3 kg/m2, respectively. 351 
Previous studies have shown higher cord blood concentrations of HCB62, 4,4’-DDE62, 352 
4,4’-DDT62 and PBDEs32 and lower concentrations of PCBs32 at higher maternal 353 
BMI. These previous results are in agreement with the cord blood concentrations 354 
differences between Valencia and Menorca for PBDEs and PCBs but not for HCB and 355 
DDTs. 356 
Other maternal indicators such as previous lactation or education level do not 357 
show significant differences between the two cohorts. They are therefore unlikely 358 
causes of variation. 359 
One distinct feature of the cord blood OHC concentration differences of these 360 
two cohorts is the strong grouping of organochlorine and organobromine compounds, 361 
which exhibit higher OC levels in Menorca than Valencia (Tables 4 and 6), and show 362 
higher PBDEs levels in Valencia than Menorca (Table 2). This contrast is observed 363 
irrespectively of OC origin, either agricultural or industrial. This OHC grouping may 364 
reflect temporal differences in the recruitment of the newborns from the two cohorts. 365 
The use of the above mentioned OCs has declined as consequence of legal 366 
regulations5 which were aimed to decrease DDTs, PCBs, HCHs and HCB. In contrast, 367 
PBDE use increased after OC restriction and actions to decrease their environmental 368 
impact have only been implemented recently. This time delay in banning 369 
organochlorine and organobromine groups is consistent with the earlier collection of 370 
cord blood samples in Menorca than in Valencia.  371 
Studies of temporal trends of OHC in the area are very scarce. One recent 372 
paper reported a general decrease in PCB concentrations in breast milk samples 373 
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collected between 1998 and 2007 in Catalonia64, a region located north of Valencia. 374 
These results are consistent with those observed in other studies concerning countries 375 
submitted to the same OC regulations as Spain showing a common decreasing trend 376 
of OC concentrations in human tissues65-67. However, the OC medians of the two 377 
cohorts involve concentration differences of about two times, e.g. 0.38 and 0.65 ng/ml 378 
for PCBs, 0.24 and 0.68 ng/ml for HCB, 0.092 and 0.19 ng/ml for β-HCH or 0.53 and 379 
0.94 ng/ml for 4,4’-DDE in Valencia and Menorca, respectively. These strong 380 
differences are difficult to attribute to the single effect of cord blood collection from 381 
babies born in a seven year interval. Possibly, additional effects such as local 382 
differences or others may also determine the OHC concentrations of newborns from 383 
the two cohorts. 384 
In this respect, the average congener PCB distributions of Valencia and 385 
Menorca are clearly different (Fig. 3). While CB 153 and CB 138 are found in higher 386 
proportion than CB 180 in the former, CB 180 is the predominant congener in the 387 
latter. This contrast suggests an influence from different PCB sources in both cohorts. 388 
As indicated above, fish and sea food are common elements of the diet in both of 389 
them. However, in Menorca fish is essentially obtained from local fishing activities 390 
developed in the western Mediterranean whereas in Valencia consumption is 391 
essentially related to the general Spanish market trading which includes a significant 392 
proportion of fish from the Atlantic Ocean. The PCB distributions of some fish from 393 
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Mothers N (%)† 
Age:   30.1(4.8)a 28.5(4.4)a ** 
<25 27(15.5) 21(23.1) 
25-29 51(29.3) 36(39.6) 
30-34 64(36.8) 27(29.7) 
≥35 32(18.4) 4(4.4) 
Pre-pregnancy BMIb:  24.3(4.6)a 22.5(3.4)a ** 
Underweight (BMI<18.5) 5(2.9) 4(4.4) 
Normal  (18.5≤BMI<25) 108(62.1) 68(74.7) 
Overweight (25≤BMI<30) 42(24.1) 11(12.1) 
Obese (BMI≥30) 19(10.9) 3(3.3) 
Previous Lactacion 14.9(30.0)a 18.5(14.2)a 
≤24 weeks 137(78.7) 63(69.2) 
 >24 weeks 36(20.7) 25(27.2) 
Education Level:    
 Up to Primary 61(35.1) 39(40.9) 
 Secondary 68(39.1) 34(37.4) 
 University 45 (25.9) 15 (16.5) 
Newborns N (%)† 
Sex:   
 Male 78(44.8) 45(49.5) 
 Female 96(55.2) 43(47.3) 
Birth-weight (g): 3317(470)a 3225(425)a 
<2500 g 9(5.2) 5(5.5) 
 ≥2500 g 165(94.8) 83(91.2) 
Birth lenght (cm) 50.2(2.1)a 49.2(1.6)a  ** 
Gestagional age (weeks): 39.7(1.5)a 39.4(1.5)a 
 <37 weeks 8(4.6) 4(4.4) 
 ≥37 weeks 166(95.4) 87(95.6) 
aArithmetic mean + Standard deviation; bBMI=Body mass index; † Numbers do not always 669 
sum  total number of participants because of missing values. ** P<0.05 (P value from χ2 –test 670 
or Student’s  T-test) 671 
 672 
  673 
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Table 2. PBDES concentrations in cord blood serum from Menorca and Valencia 674 


















BDE 47 4.1(6.1) 2.4 nd1 18 nd-43 2.8(3.5) 2.1 nd1 10.4 nd-17 
BDE 99 2.7(4.8) 1.5 nd1 10 nd-41 1.3(2.2) nd3 nd3 5.4 nd-12 
BDE 100 2.3(5.3) nd1 nd1 11 nd-46 1.1(3.4) nd3 nd3 8.5 nd-26 
BDE153 1.3(1.8) nd2 nd2 4.6 nd-9.8 nd nd1 nd1 nd nd 
BDE183 0.6(2.9) nd2 nd2 3.6 nd-27 0.05(0.5) nd4 nd4 nd nd-4.8 
ΣPBDEsb 11(17) 6.5 1.4 42 nd-140 5.4(6.8) 2.8 nd 18 nd-33 
aArithmetic mean (standard deviation);b Sum of PBDE congeners analyzed individually; nd: below limit of 675 
detection: 1<0.003 ng/mL; 2<0.002 ng/mL; 3<0.006 ng/mL; 4<0.004 ng/mL 676 
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Table 3. Medians of PBDE congeners (ng/g lipid) found in umbilical cord blood serum from previous studies. 677 





















Madrid (Spain) 44 2003-2004 3.3 4.3 2.3 0.53 1.3 17 18 
Sweden 15 2000-2001 0.98 0.07 0.07 0.17 0.01 1.69 31 
Groningen (Netherlands) 69 2001-2002 0.5 0.1 0.1 0.9 na 3.9 30 
Tolouse (France) 91 2004-2006 nd 7.4 1.4 0.48 0.59 12.3 27 
Indiana (United States) 12 2001 25 7.7 4.1 4.4 nd 39 33 
Baltimore (United States) 297 2004-2005 13.3 4.3 2.3 2.6 0.9 26.6 32 
Indiana (United States) 16 2003-2004 13 5.3 2.6 2.7 1.3 31 34 
New York (United  States) 210 2001 11.2 3.2 1.4 0.7 0.6 18.4 35 
South China 21 2005 1.4 0.47 0.22 0.8 0.2 3.9 28 
Japan 8 2005-2006 0.57 nd 0.18 0.36 nd 0.65 29 
Singapore 41 2006 1.69 0.35 na na na 3.3 36 
Copenhagen (Denmark) 51 2007 nd nd nd 0.5 nd 0.95 37 
Guiyu (China) 102 2007 2.1 0.64 0.18 0.99 0.91 13.8 38 




Table 4. PCBs concentrations in cord blood serum from Menorca and Valencia.  681 
Mean(SD) Median Percentile Range Mean(SD) Median Percentile Range Compounds 
  25 95    25 95  
 Valencia (n = 172) 
ng/ml 
[ng/g lipid] 
Menorca (n = 88) 
ng/ml 
[ng/g lipid] 
































































































































































aArithmetic mean (standard deviation);b Sum of PCB congeners analyzed individually; nd: below limit of 682 
detection: 1<0.07 ng/mL; 2<0.06 ng/mL; 3<0.03 ng/mL; 4<0.005 ng/mL; 5<0.02 ng/mL 683 
 684 
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Table 5. Arithmetic mean concentrations of OCs in umbilical cord blood serum reported in previous studies. 685 
 686 


















Ribera d’Ebre (Catalonia, Spain) 69 1997-1999 0.36b 1.1b 0.26b 0.83b 0.05 b 10 
Brescia (Italy) 70 2006 0.23b 0.05b na 0.25b nd 39 
Rotterdam (Netherlands) 382 1990-1992 0.45 na na na na 43 
North Netherlands 51 1998-2000 [345] na na na na 44 
Flanders (Belgium) 1054 2002-2003 [108] [25.4] na [164] na 42 
Michalovce (Slovakia) 92 2002-2004 1.21 na na na na 45 
Wielkopolska (Poland) 17 2004 [65.5] [21] [2.6] [365] [19.6] 46 
Sweeden 15 2000-2001 [104] c na na na na 31 
Faroe Island (Denmark) 316 1986-1987 [155] na na [110] na 47 
Chukotka (Russia) 48 2001-2002 1.5 0.69 0.8 0.89 na 48 
Northern Québec (Canada) 98 1995-2001 [350] [55.6] na [387] [16] 49 
Québec (Canada) 656 1993-1995 0.51b 0.04b na 0.41b na 50 
Artic Canada 407 1994-1999 0.36 0.10 0.07 0.53 0.03 51 
Maryland (United States) 297 2004-2005 [16.9] c na na [53.5] c na 32 
Oaxaca (Mexico) 86 2000 na na na 7540b 2370b 41 
Veracruz (Mexico) 60 1997-1998 na 0.8 0.7 6.0 0.8 52 
Rio de Janeiro (Brasil) 10 1997-1998 na 0.13 0.54 0.76 nd 53 
Chiba and Yamanashi (Japan) 32 2002-2003 [63.8] [10.9] [33.8] [33] nd 54 
Zhejiang (China) 60 2005 [194] b [6.15] b [2.33] b [83] b na 55 
New Delhi (India) 23 2006-2008 na na 3.59 1.98 0.93 56 
Singapore 41 2006 [38.2] na [85.4] [402] [34.5] 57 
athe concentrations are reported in the same units as given in the referenced studies. bthe concentrations are reported according to the number of congeners 687 




Table 6. Organochlorine pesticides concentrations in cord blood serum from Menorca and 691 
Valencia.  692 
 693 
aArithmetic mean (standard deviation); nd: below limit of detection: 1<0.008 ng/mL; 2<0.009 ng/mL; 3<0.01 694 
ng/mL 695 
Mean(SD) Median Percentile Range Mean(SD) Median Percentile Range Compound 
  25 95    25 95  
 Valencia (n = 172) 
ng/ml 
[ng/g lipid] 




















































































Figure Captions 696 
 697 
Figure 1. Areas of study 698 
 699 
Figure 2. Mean concentrations (ng/g lipid) and standard error bars of the PBDE congeners (a) 700 
and contribution of the different individual congeners to the total Sum of BDEs (b) in 701 
Valencia and Menorca cord serum samples 702 
 703 
Figure 3. Mean concentrations (ng/g lipid) and standard error bars of the PCB congeners (a) 704 
and contribution of the different individual congeners to the total Sum of PCBs (b) in 705 
Valencia and Menorca cord serum samples 706 
 707 
Figure 4. Frequency histograms showing the distribution of organohalogen compounds in 708 
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